InnoPharmax Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 28.389 million compared to TWD 55.666 million a year ago. Operating loss was TWD 31.630 million compared to TWD 18.271 million a year ago. Net loss was TWD 41.276 million compared to TWD 23.163 million a year ago. Basic loss per share from continuing operations was TWD 0.48 compared to TWD 0.3 a year ago.